Watchlist Price Alert

UroGen Pharma Ltd. (URGN)

NASDAQ: URGN · Real-Time Price · USD

14.15

-0.19 (-1.32%)

At close: Jun 17, 2025, 10:37 AM

UroGen Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-126.87M	-102.24M	-109.78M	-110.82M	-128.48M	-105.15M	-75.66M	-20M	-1.94M
Depreciation & Amortization	1.19M	1.71M	1.82M	1.77M	2.04M	1.32M	417K	207K	213K
Stock-Based Compensation	13.11M	9.34M	10.58M	23.11M	28.02M	29.97M	30.64M	6.3M	1.97M
Other Working Capital	2.45M	3.27M	-5.24M	-7.57M	3.89M	1.39M	-650K	1.35M	917K
Other Non-Cash Items	10.88M	11.48M	16.13M	-1.18M	-1.54M	-910K	100K	165K	2.74M
Deferred Income Tax	n/a	n/a	n/a	15.32M	439K	-572K	n/a	n/a	n/a
Change in Working Capital	4.93M	3.34M	-6.31M	-13.11M	-6.37M	4.32M	7.16M	3.76M	1.21M
Operating Cash Flow	-96.77M	-76.38M	-87.56M	-84.89M	-105.89M	-71.02M	-37.33M	-9.57M	4.19M
Capital Expenditures	-295K	-194K	-254K	-752K	-1.22M	-325K	-560K	-271K	-695K
Cash Acquisitions	n/a	n/a	-1.31M	-4.82M	-94.45M	n/a	n/a	n/a	n/a
Purchase of Investments	-128.02M	-49.83M	-63.01M	-51.9M	-29.69M	-197.69M	-54K	-36M	-24K
Sales Maturities Of Investments	107.7M	49.07M	64.32M	56.72M	124.14M	52.59M	35.9M	n/a	n/a
Other Investing Acitivies	n/a	n/a	1.31M	4.82M	94.45M	-172K	-54K	-105K	-98K
Investing Cash Flow	-20.61M	-953K	1.06M	4.07M	93.24M	-145.59M	35.29M	-36.38M	-793K
Debt Repayment	24.49M	n/a	95.78M	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	49.57M	1.35M	72.32M	674K	3.59M	2.19M	744K	-9K
Financial Cash Flow	194.62M	116.93M	97.13M	72.32M	16.53M	165.25M	66.42M	61.59M	-9K
Net Cash Flow	77.24M	39.6M	10.63M	-8.5M	3.88M	-51.36M	64.37M	15.64M	3.39M
Free Cash Flow	-97.06M	-76.57M	-87.81M	-85.64M	-107.1M	-71.34M	-37.89M	-9.84M	3.49M